Search results
Results From The WOW.Com Content Network
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates , finished formulations , food supplements, biotechnology products and pharmaceutical machinery.
Cadila was founded in 1952 by Ramanbhai Patel (1925–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Indravadan Modi. [8]In 1995, the Patel and Modi families split; the Modi family's share was moved into a new company called Cadila Pharmaceuticals, and Cadila Healthcare became the Patel family's holding company.
In 2006, Cadila Healthcare acquired a 14.96% stake in the company. [10] Cadila's stake in the company increased to over 70% in 2008, after the merger of Cadila's consumer goods business, which included sugar substitute brand Sugar Free and EverYuth range of skincare products, into Carnation. [11]
Gujarat has become a hub for the pharmaceutical industry, with several established companies such as Torrent Pharmaceuticals, Zydus Lifesciences, Cadila Pharmaceuticals, Alembic Pharmaceuticals, Sun Pharma, Claris, Intas Pharmaceuticals, and Dishman Pharmaceuticals having operations in the state.
When he took over the Cadila Healthcare, he was faced with two challenges: His was a Rs 200-crore company whereas his overheads including management, research, company expenses, and staff worked out to Rs 400 crore. It was difficult to make two ends meet. [4] They were the first Indian company to develop a drug for high-cholesterol diabetics.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Cadila Pharmaceuticals Ltd: Ahmedabad: Pharmaceuticals: 21 Chemcon Speciality Chemicals Ltd Vadodara: ... Mangalam Drugs and Organics Ltd Ahmedabad: Pharmaceuticals
India's Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to ...